Competitors Medtronic (Dublin) and C.R. Bard (Murray Hills, N.J.) placed a huge spotlight on drug-coated balloons (DCB) with two studies the companies released this week, during this year's Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Read More
